GeneralProtocol Exemption Determination Letter Sample Survey Clinic Responses IRBIRB Approval Letter IRB Example Data SummariesApril 22, 2020 April 29, 2020 May 8, 2020 COVID-19 Publications Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Meeting Presentations March 26th, 2021 Meeting FAQsAny questions please email: oebekozien@t1dexchange.org nrioles@t1dexchange.org Click here to view FAQs
Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry
Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers
Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes.
